Candel Therapeutics (CADL) shifts to late-stage oncology with CAN-2409 Phase III wins and BLA catalyst. Read here for a ...

AVE has made a breakthrough with a phase III insomnia trial for its soft gel cannabidiol to manage sleeplessness. ... Read ...

GURU Nayagam PP guides aspirants on how to pick the right career course and college based on their entrance scores and ...

This could be a key move for future growth.

Brandon Capital, a life sciences venture capital firm has exited from its investment in Myricx Bio, following its agreement to be acquired by Novartis for US$1.5 billion ($2.2bn).

The company faces a long road ahead if it hopes to stand out in the crowded obesity development scene, and iBio’s significant change in course in recent years could heap further scrutiny on the ...

In a Q&A, Kenneth Chien, no longer with Moderna, predicts the company's mRNA cancer vaccine will be transformative for ...

Delhi University has initiated the admission process for one-year postgraduate (PG) courses for the 2026-27 academic session.

In a major reform aimed at standardising postgraduate medical education in the country, the National Medical Commission (NMC) ...

Mornings like we had on Wednesday are exactly why I get up and do this show every single day the market is open. UniQure NV ...

Regencell Bioscience Holdings Limited (RGC) focuses on TCM-based treatments for ADHD and Autism, targeting significant ...

After earning her biochemistry and biotechnology bachelor’s, Allison Lendman is staying at UMSL in an accelerated master’s ...